Doha, Qatar: Specialist physicians from across the globe convened in Doha for a two-day event coordinated by Weill Cornell Medicine-Qatar (WCM-Q) to share the latest best practice on the diagnosis and ...
THE WOODLANDS, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced data from a study of patients describing the physical and psychological impact of ...
Last patient last visit (LPLV) was reached for the 127 adult and elderly patients enrolled into the 12-week placebo-controlled trial with nispomeben (NRD.E1) Topline results are expected in November ...
A Vertex Pharmaceuticals drug viewed as a successor to a non-opioid pill that won a landmark FDA approval earlier this year has failed a mid-stage clinical trial, dealing a setback to the company’s ...
After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit a snag on its path to expand the potential blockbuster’s reach into ...
In a groundbreaking review published in Current Molecular Pharmacology, researchers from Teerthanker Mahaveer University have mapped the molecular mechanisms behind diabetic neuropathy and nephropathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback